Alexion Pharmaceuticals

Alexion Pharmaceuticals Inc. Reports Operating Results (10-Q)

GuruFocus Updates (Free subscription) | 11/06/2009

By 10qk. Alexion Pharmaceuticals Inc. ( ALXN ) filed Quarterly Report for the period ended 2009-09-30. Read more » »

Alexion Pharmaceuticals Inc. (ALXN) CEO Leonard Bell sells 20,400 Shares

GuruFocus Updates (Free subscription) | 11/03/2009

By insider. CEO of Alexion Pharmaceuticals Inc. ( ALXN ) Leonard Bell sells 20,400 shares of ALXN on 11/02/2009 at an average price of $43.82 a share. Read more » »

Alexion Pharmaceuticals (ALXN) NewsBite - ALXN Sets New High On Strong Earnings Report

MarketIntelligenceCenter.com (Free subscription) | 10/22/2009

Alexion Pharmaceuticals (ALXN) hit a new 52-Week high of $47.61 so far today. Currently the stock is up $2.88 (6.53%) to $47.01 on 1,764,442 shares traded. Today's high is up $18.85 from a 52-Week Low of $28.16. Alexion Pharmaceuticals stock has been showing support around $43.01 and resistance in the $45.73 range. Technical indicators for the stock are bullish and S&P gives ALXN...

Alexion to Present at Lazard Capital Markets 6th Annual Healthcare Conference

Business Wire (Free subscription) | 11/11/2009

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Dr. Leonard Bell, Chief Executive Officer of Alexion Pharmaceuticals, will present at Lazard Capital Markets 6th Annual Healthcare Conference in New York City at 10:00 a.m. ET on Wednesday, November 18, 2009. An audio webcast of Dr. Bell’s remarks will be available live. You can access...

• SuperGen to Present at Lazard Healthcare Conference on November 18, 2009 - The Earth Times Online Newspaper
• Allos Therapeutics to Present at Upcoming Conferences in November - The Earth Times Online Newspaper
• See the 5 articles on the same subject

Researchers To Present Additional Data On Soliris(R) (eculizumab) For The Treatment Of Patients With PNH At The ASH Annual Meeting

Medical News Today (Free subscription) | 11/12/2009

Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) announced that researchers are scheduled to present data relating to Soliris® (eculizumab) as a treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH) during the 51st Annual Meeting of the American Society of Hematology (ASH), to be held December 5 - 8, 2009 at the Ernst N. Morial Convention Center in New Orleans.

Researchers to Present Additional Data on Soliris® (eculizumab) for the Treatment of Patients With PNH at the ASH Annual Meeting

Business Wire (Free subscription) | 11/11/2009

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that researchers are scheduled to present data relating to Soliris® (eculizumab) as a treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH) during the 51st Annual Meeting of the American Society of Hematology (ASH), to be held December 5 – 8, 2009 at the Ernst N. Morial Convention...

Alexion to Present at Credit Suisse’s 2009 Healthcare Conference

Business Wire (Free subscription) | 11/05/2009

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Dr. Leonard Bell, Chief Executive Officer of Alexion Pharmaceuticals, will present at Credit Suisse’s 2009 Healthcare Conference in Phoenix, Arizona at 8:00 a.m., local time (10:00 a.m. ET) on Thursday, November 12, 2009. An audio webcast of Dr. Bell’s remarks will be available...

Alexion to Present at the Oppenheimer 20th Annual Healthcare Conference

Business Wire (Free subscription) | 10/28/2009

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Dr. Leonard Bell, Chief Executive Officer of Alexion Pharmaceuticals, will present at the Oppenheimer 20th Annual Healthcare Conference in New York City at 3:55 p.m. ET on Wednesday, November 4, 2009. An audio webcast of Dr. Bell’s remarks will be available live. You can access the...

Living On Biologics At $32,000 A Month

Pharmalot (Free subscription) | 11/03/2009

... and severe pain. But he can’t switch to a cheaper, generic version of Soliris , which is sold by Alexion Pharmaceuticals. But once his insurance cap is hit, he has only a couple of options, including costly independent plans. And Day can’t ride a bus to Canada for a lower-cost version.

Alexion to Present at the 20th Annual Healthcare Conference

Business Wire (Free subscription) | 10/28/2009

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Dr. Leonard Bell, Chief Executive Officer of Alexion Pharmaceuticals, will present at the 20th Annual Healthcare Conference in New York City at 3:55 p.m. ET on Wednesday, November 4, 2009. An audio webcast of Dr. Bell’s remarks will be available live. You can access the webcast at:...

Alexion Reports Third Quarter 2009 Results

Business Wire (Free subscription) | 10/22/2009

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (“Alexion” or the “Company,” NASDAQ: ALXN) today announced financial results for the quarter ended September 30, 2009. Third Quarter 2009 Financial Results: For the three months ended September 30, 2009, Alexion reported total revenues of $102.6 million from net product sales of Soliris® (eculizumab),...

Biggest Stock Gainers 10/22/09 October 22, 2009

Stock Market Analysis (Free subscription) | 10/22/2009

... (PNC) iRobot Corporation (IRBT) AmeriCredit Corp. (ACF) Leap Wireless International Inc. (LEAP) Alexion Pharmaceuticals, Inc. (ALXN) MetroPCS Communications Inc. (PCS) The McClatchy Company (MNI) Spreadtrum Communications Inc. (SPRD) QLogic Corp. (QLGC) More............ Today's Biggest Stock Market Gainers - Top 2009 Stock Gainers - Top 2009 Penny Stocks For the latest updates on the stock...

Pre Market Stock Gainers & Losers 10/22/09

Stock Market Analysis (Free subscription) | 10/22/2009

... Corporation (CHIP) - No News Rodman & Renshaw Capital Group, Inc. (RODM) - News - Earnings Alexion Pharmaceuticals, Inc. (ALXN) - News - Earnings NetSol Technologies Inc. (NTWK) - News - New Contract PNC Financial Services Group Inc. (PNC) - News - Earnings Generex Biotechnology Corp. (GNBT) - No News Pre Market Stock Losers - 10/22/09 TriQuint Semiconductor, Inc. (TQNT) - News - Earnings...

StockSource.us Reports MNDP Driving Growth With New Technologies

EmailWire.Com (Free subscription) | 10/23/2009

... Oil & Gas Corp. (AMEX: ), Augusta Resource Corp. (AMEX: ), East West Bancorp Inc. (NasdaqGS: ), Alexion Pharmaceuticals Inc. (NasdaqGM: ), Terremark Worldwide Inc. (NasdaqGM: ), Washington Federal Inc. (NasdaqGS: ), OSI Pharmaceuticals Inc. (NasdaqGS: ), Atlantic Wind & Inc. (Other OTC: )Featured Stock:MUNDUS GROUP INC.: MNDP)For A Comprehensive Coverage of this Stock Please Visit:E-mail:...

Trading Radar for 10/22: AT&T (T), McDonalds (MCD), Amazon.com (AMZN), 3M (MMM), Dow Chemical (DOW), UPS (UPS) Report

StreetInsider.com News Articles (Free subscription) | 10/21/2009

The Trading Radar highlights key earnings and economic announcements for tomorrow's trading session: Before Market Opens: Economics: 8:30am ET Initial Jobless Claims – Street Sees 517K Earnings: Akeena Solar (NASDAQ: AKNS) – consensus loss $0.10 Alaska Air Group, Inc. (NYSE: ALK) – consensus EPS $2.26 Alexion Pharmaceuticals (NASDAQ: ALXN) - consensus EPS $0.21 AT&T (NYSE:...